Heat shock protein-60 and risk for cardiovascular disease

Current Pharmaceutical Design

Volumn 17, Issue 33, 2011, Pages 3662-3668

  Rizzo, Manfredi ^a,b   Macario, Alberto J L ^b,c   de Macario, Everly Conway ^c   Gouni Berthold, Ioanna ^d   Berthold, Heiner K ^e   Rini, Giovam Battista ^a   Zummo, Giovanni ^a   Cappello, Francesco ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Euro Mediterranean Institute of Science and Technology   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atherosclerosis; Cardiomyocytes; Cardiovascular disease; Chaperonin; Heart failure; Heat shock protein 60

Indexed keywords

APOLIPOPROTEIN B; AUTOANTIBODY; CHAPERONIN; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 60; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 206; PROTEIN BAK; PROTEIN BAX; SOMATOMEDIN C RECEPTOR; TRANDOLAPRIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MEMBRANE; CELL STRESS; CELL SURVIVAL; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL PNEUMONIA; CONGESTIVE CARDIOMYOPATHY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; CYTOSOL; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HELICOBACTER PYLORI; HUMAN; HYPERTENSION; MITOCHONDRION; MOLECULAR MIMICRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYGEN CONSUMPTION; PATHOGENESIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SINUS RHYTHM; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHAPERONIN 60; HEART FAILURE; HUMANS; HYPERTENSION; MYOCYTES, CARDIAC; REPERFUSION INJURY; RISK;

EID: 82055206629     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798220981     Document Type: Review

References (101)

1. Am Heart Association. Heart Disease and Stroke Statistics- 2003 Update. http: //www.americanheart.org/downloadable/heart/1040391091015HDS_Stats_03.pdf.
2. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
3. Macario AJL, Conway de Macario E. Molecular chaperones: multiple functions, pathologies, and potential applications. Front Biosci 2007; 12: 2588-600.
4. Macario AJL, Cappello F, Zummo G, Conway de Macario E. Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems. Ann N Y Acad Sci 2010; 1197: 85-93.
5. Macario AJL, Conway de Macario E. Sick chaperones, cellular stress, and disease. N Engl J Med 2005; 353: 1489-501.
6. Macario AJL, Conway de Macario E. Chaperonopathies by defect, excess, or mistake. Ann N Y Acad Sci 2007; 1113: 178-91.
7. Brocchieri L, Conway de Macario E, Macario AJL. Chaperonomics, a new tool to study ageing and associated diseases. Mech Ageing Dev 2007; 128: 125-36.
8. Zügel U, Kaufmann SH. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12: 19-39.
9. Corrao S, Campanella C, Anzalone R, et al. Human Hsp10 and Early Pregnancy Factor (EPF) and their relationship and involvement in cancer and immunity: current knowledge and perspectives. Life Sci 2010; 86: 145-52.
10. Cappello F, Conway de Macario E, Marasà L, Zummo G, Macario AJL. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther 2008; 7: 801-9.
11. Knowlton AA, Kapadia S, Torre-Amione G, et al. Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol 1998; 30: 811-8.
12. Latif N, Taylor PM, Khan MA, Yacoub MH, Dunn MJ. The expression of heat shock protein 60 in patients with dilated cardiomyopathy. Basic Res Cardiol 1999; 94: 112-9.
13. Hamilton KL, Powers SK, Sugiura T, et al. Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins. Am J Physiol Heart Circ Physiol 2001; 281: H1346-52.
14. Marini M, Lapalombella R, Margonato V, et al. Mild exercise training, cardioprotection and stress genes profile. Eur J Appl Physiol 2007; 99: 503-10.
15. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264-72.
16. Sakai J, Ishikawa H, Kojima S, Satoh H, Yamamoto S, Kanaoka M. Proteomic analysis of rat heart in ischemia and ischemiareperfusion using fluorescence two-dimensional difference gel electrophoresis. Proteomics 2003; 3: 1318-24.
17. Ascensão A, Magalhães J, Soares J, et al. Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol 2005; 100: 451-60.
18. Simoncíková P, Ravingerová T, Barancík M. The effect of chronic doxorubicin treatment on mitogen-activated protein kinases and heat stress proteins in rat hearts. Physiol Res 2008; 57 Suppl 2: S97-S102.
19. Toga W, Tanonaka K, Takeo S. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril. Biol Pharm Bull 2007; 30: 105-10.
20. Schett G, Metzler B, Kleindienst R, et al. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc Res 1999; 42: 685-95.
21. Novo G, Cappello F, Rizzo M, et al. Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. Transl Res. 2011; 157: 285-92.
22. Schäfler AE, Kirmanoglou K, Gallmeier U, Pecher P, Hannekum A, Schumacher B. Heat shock protein 60 expression in patients undergoing cardiac operations. J Cardiovasc Surg (Torino) 2003; 44: 187-90.
23. Sarri S, Shaw SM, Gieschen-Krische MA, Archer L, Yonan N, Fildes JE. Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection. Transpl Immunol 2009; 21: 140-2.
24. Ovelgönne JH, Van Wijk R, Verkleij AJ, Post JA. Cultured neonatal rat heart cells can be preconditioned by ischemia, but not by heat shock. The role of stress proteins. J Mol Cell Cardiol 1996; 28: 1617-29.
25. Heads RJ, Yellon DM, Latchman DS. Differential cytoprotection against heat stress or hypoxia following expression of specific stress protein genes in myogenic cells. J Mol Cell Cardiol 1995; 27: 1669-78.
26. Lau S, Patnaik N, Sayen MR, Mestril R. Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury. Circulation 1997; 96: 2287-94.
27. Lin KM, Lin B, Lian IY, Mestril R, Scheffler IE, Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemiareoxygenation. Circulation 2001; 103: 1787-92.
28. [Li Y, Si R, Feng Y, et al. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem. 2011 Jul 20. [Epub ahead of print]
29. Singh B, Patel HV, Ridley RG, Freeman KB, Gupta RS. Mitochondrial import of the human chaperonin (HSP60) protein. Biochem Biophys Res Commun 1990; 169: 391-6.
30. Kirchhoff SR, Gupta S, Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 2002; 105: 2899-904.
31. Knowlton AA, Gupta S. HSP60, Bax, and cardiac apoptosis. Cardiovasc Toxicol 2003; 3: 263-8.
32. Gupta S, Knowlton AA. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 2002; 106: 2727-33.
33. Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007; 120: 3045-52.
34. Shan ZX, Lin QX, Deng CY, et al. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett 2010; 584: 3592-600.
35. Sidorik L, Kyyamova R, Bobyk V, et al. Molecular chaperone, HSP60, and cytochrome P450 2E1 co-expression in dilated cardiomyopathy. Cell Biol Int 2005; 29: 51-5.
36. Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 2007; 292: H3052-6.
37. Lin L, Kim SC, Wang Y, et al. HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 2007; 293: H2238-47.
38. Kim SC, Stice JP, Chen L, et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ Res 2009; 105: 1186-95.
39. Tanonaka K, Yoshida H, Toga W, Furuhama K, Takeo S. Myocardial heat shock proteins during the development of heart failure. Biochem Biophys Res Commun. 2001; 283: 520-5.
40. De Souza AI, Cardin S, Wait R, et al. Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure. J Mol Cell Cardiol 2010; 49: 851-63.
41. Toga W, Tanonaka K, Takeo S. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril. Biol Pharm Bull 2007; 30: 105-10.
42. Giannessi D, Colotti C, Maltinti M, et al. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 2007; 12: 265-74.
43. Wang Y, Chen L, Hagiwara N, Knowlton AA. Regulation of heat shock protein 60 and 72 expression in the failing heart. J Mol Cell Cardiol 2010; 48: 360-6.
44. Pockley AG, De Faire U, Kiessling R, Lemne C, Thulin T, Frostegård J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 2002; 20: 1815-20.
45. Sellers MB, Newby LK. Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J 2011; 161: 241-6.
46. Stiell IG, Macle L, CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can J Cardiol 2011; 27: 38-46.
47. Schäfler AE, Kirmanoglou K, Balbach J, Pecher P, Hannekum A, Schumacher B. The expression of heat shock protein 60 in myocardium of patients with chronic atrial fibrillation. Basic Res Cardiol 2002; 97: 258-61.
48. Schäfler AE, Kirmanoglou K, Pecher P, Hannekum A, Schumacher B. Overexpression of heat shock protein 60/10 in myocardium of patients with chronic atrial fibrillation. Ann Thorac Surg 2002; 74: 767-70.
49. Yang M, Tan H, Cheng L, et al. Expression of heat shock proteins in myocardium of patients with atrial fibrillation. Cell Stress Chaperones 2007; 12: 142-50.
50. [Cao H, Xue L, Xu X, et al. Heat shock proteins in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. Cell Stress Chaperones. 2011 Apr 1. [Epub ahead of print]
51. Johnson RB, Fearon K, Mason T, Jindal S. Cloning and characterization of the yeast chaperonin HSP60 gene. Gene 1989; 84: 295-302.
52. Schwock J, Kirchberger J, Edelmann A, Kriegel TM, Kopperschläger G. Interaction of 6-phosphofructokinase with cytosolic proteins of Saccharomyces cerevisiae. Yeast 2004; 21: 483-94.
53. Shamaei-Tousi A, Stephens JW, Bin R, et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J. 2006; 27: 1565-70.
54. Ugurlucan M, Erer D, Kalko Y, et al. Aortic stiffness in diabetes mellitus--association with glutamine and heat shock protein 70 expression: a pilot study based on an experimental rodent model. Expert Opin Ther Targets. 2009; 13: 267-74.
55. Shan YX, Yang TL, Mestril R, Wang PH. Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem 2003; 278: 45492-8.
56. Chen HS, Shan YX, Yang TL, et al. Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 2005; 54: 175-81.
57. Wick G. Atherosclerosis--an autoimmune disease due to an immune reaction against heat-shock protein 60. Herz 2000; 25: 87-90.
58. Grundtman C, Kreutmayer SB, Almanzar G, Wick MC, Wick G. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol 2011; 31: 960-8.
59. Mandal K, Foteinos G, Jahangiri M, Xu Q. Role of antiheat shock protein 60 autoantibodies in atherosclerosis. Lupus 2005; 14: 742-6.
60. Knoflach M, Bernhard D, Wick G. Anti-HSP60 immunity is already associated with atherosclerosis early in life. Ann N Y Acad Sci 2005; 1051: 323-31.
61. Foteinos G, Xu Q. Immune-mediated mechanisms of endothelial damage in atherosclerosis. Autoimmunity 2009; 42: 627-33.
62. Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000; 102: 14-20.
63. Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegård J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 2000; 36: 303-7.
64. Xiao Q, Mandal K, Schett G, et al. Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study. Stroke 2005; 36: 2571-6.
65. Hoymans VY, Bosmans JM, Van Herck PL, Ieven MM, Vrints CJ. Implications of antibodies to heat-shock proteins in ischemic heart disease. Int J Cardiol 2008; 123: 277-82.
66. Zhang X, He M, Cheng L, et al. Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation 2008; 118: 2687-93.
67. Burian K, Kis Z, Virok D, et al. Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2001; 103: 1503-8.
68. Wysocki J, Karawajczyk B, Górski J, et al. Human heat shock protein 60 (409-424) fragment is recognized by serum antibodies of patients with acute coronary syndromes. Cardiovasc Pathol 2002; 11: 238-43.
69. Zhang X, He MA, Cheng L, et al. Joint effects of antibody to heat shock protein 60, hypertension, and diabetes on risk of coronary heart disease in Chinese. Clin Chem 2008; 54: 1046-52.
70. Chung SW, Kang HS, Park HR, Kim SJ, Kim SJ, Choi JI. Immune responses to heat shock protein in Porphyromonas gingivalisinfected periodontitis and atherosclerosis patients. J Periodontal Res 2003; 38: 388-93.
71. Ausiello CM, Fedele G, Palazzo R, Spensieri F, Ciervo A, Cassone A. 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells. Microbes Infect 2006; 8: 714-20.
72. Mori Y, Kitamura H, Song QH, Kobayashi T, Umemura S, Cyong JC. A new murine model for atherosclerosis with inflammation in the periodontal tissue induced by immunization with heat shock protein 60. Hypertens Res 2000; 23: 475-81.
73. Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJL. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog 2009; 5: e1000552.
74. Pfister G, Stroh CM, Perschinka H, et al. Detection of HSP60 on the membrane surface of stressed human endothelial cells byatomic force and confocal microscopy. J Cell Sci 2005; 118: 1587-94.
75. Heltai K, Kis Z, Burian K, et al. Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease. Atherosclerosis 2004; 173: 339-46.
76. Perschinka H, Mayr M, Millonig G, et al. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 1060-5.
77. Zhu J, Katz RJ, Quyyumi AA, et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation 2004; 109: 36-41.
78. LaVerda D, Kalayoglu MV, Byrne GI. Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol 1999; 7: 64-71.
79. Campanella C, Marino Gammazza A, Mularoni L, Cappello F, Zummo G, Di Felice V. A comparative analysis of the products of GROEL-1 gene from Chlamydia trachomatis serovar D and the HSP60 var1 transcript from Homo sapiens suggests a possible autoimmune response. Int J Immunogenet 2009; 36: 73-8.
80. Choi J, Lee SY, Kim K, Choi BK. Identification of immunoreactive epitopes of the Porphyromonas gingivalis heat shock protein in periodontitis and atherosclerosis. J Periodontal Res 2011; 46: 240-5.
81. Okada T, Ayada K, Usui S, et al. Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease. J Autoimmun 2007; 29: 106-15.
82. Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E, Oguma K. Chronic infections and atherosclerosis. Ann N Y Acad Sci 2007; 1108: 594-602.
83. Bason C, Corrocher R, Lunardi C, et al. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 2003; 362: 1971-7.
84. Lunardi C, Dolcino M, Peterlana D, et al. Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis. PLoS One 2007; 2: e473.
85. Guisasola MC, Dulín E, Almendral J, García-Barreno P. Reduction of heat shock protein antibody levels by statin therapy. Lipids 2009; 44: 317-24.
86. Gaston JS, Curry AJ, Portig I, Goodall JC, Kirkpatrick PJ. Immune responses to Chlamydia antigens in atherosclerosis. Herz 2000; 25: 73-8.
87. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 1999; 180: 780-90.
88. Park CS, Lee JY, Kim SJ, Choi JI. Identification of immunological parameters associated with the alveolar bone level in periodontal patients. J Periodontal Implant Sci. 2010; 40: 61-8.
89. Mikhailidis DP, Elisaf MS, Rizzo M, et al. "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses. Curr Vasc Pharmacol 2011; 9: 533-571.
90. Mikhailidis DP, Elisaf MS, Rizzo M, et al. "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary. Curr Vasc Pharmacol 2011; 9: 531-2.
91. de Graaf R, Kloppenburg G, Kitslaar PJ, Bruggeman CA, Stassen F. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 2006; 8: 1859-65.
92. Bielecka-Dabrowa A, Barylski M, Mikhailidis DP, Rysz J, Banach M. HSP 70 and atherosclerosis--protector or activator? Expert Opin Ther Target. 2009; 13: 307-17.
93. Hirono S, Dibrov E, Hurtado C, Kostenuk A, Ducas R, Pierce GN. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ Res 2003; 93: 710-6.
94. Esposito P, Tinelli C, Libetta C, Gabanti E, Rampino T, Dal Canton A. Impact of seropositivity to Chlamydia pneumoniae and antihHSP60 on cardiovascular events in hemodialysis patients. Cell Stress Chaperones 2011; 16: 219-24.
95. Holm TL, Nielsen J, Claesson MH. CD4+CD25+ regulatory T cells: I. Phenotype and physiology. APMIS 2004; 112: 629-41.
96. Hansen W, Westendorf AM, Buer J. Regulatory T cells as targets for immunotherapy of autoimmunity and inflammation. Inflamm Allergy Drug Targets 2008; 7: 217-23.
97. Yang K, Li D, Luo M, Hu Y. Generation of HSP60-specific regulatory T cell and effect on atherosclerosis. Cell Immunol 2006; 243: 90-5.
98. van Puijvelde GH, van Es T, van Wanrooij EJ, et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2677-83.
99. Ayada K, Yokota K, Hirai K, et al. Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis. Lupus 2009; 18: 1154-68.
100. Lu X, Chen D, Endresz V, et al. Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice. Atherosclerosis 2010; 212: 472-80.
101. Li J, Zhao X, Zhang S, Wang S, Du P, Qi G. ApoB-100 and HSP60 Peptides Exert a Synergetic Role in Inhibiting Early Atherosclerosis in Immunized ApoE-null Mice. Protein Pept Lett. 2011 Mar 17. [Epub ahead of print]